ActiGraft®
ActiGraft
Recreating the Natural Wound Healing Environment
ActiGraft, based on RedDress’ proprietary patented technology, is a FDA-cleared wound care solution that enables health care providers to produce—in real time—in vitro blood clot tissue from a patient’s whole blood. Once applied, the blood clot tissue serves as a protective covering and supports wound healing processes which naturally occur in the patient's body.
Faster Application
Can be easily prepared at the patient’s bedside in 12 minutes
Cost Effective Treatment
Provides significant savings in nursing costs and simplifies wound treatment
Patient Comfort
Fast healing with less wound interaction
Easy Integration
Seamlessly integrates into current chronic wound treatment practices
Simplified Process
Enables front line staff to easily execute ongoing wound treatment
Supports Natural Healing
Uses the patient’s own blood to support the body’s own healing processes
Take the Guessing Out of Wound Management
Standard of Care topical dressings address one or two aspects of a chronic wound bed. The ActiGraft dressing contains the fibrin matrix (derived from the patient's own blood) acting to support the body's own wound healing processes.
ActiGraft changes the way we treat chronic wounds by supporting every stage of the wound healing process and taking the guesswork out of wound treatment.
ActiGraft System Procedure
Efficient Wound Treatment
- Provides the wound with an optimal, natural healing environment, allowing the healing process to proceed unhindered.
- Weekly vs. daily application saves facility staff nursing time.
- Published results of 72% complete healing within 12 weeks.2,3,4
Simplified Procedures
- Single-use, state-of-the-art, autologous graft wound care solution.
- Designed with nurses in mind, ActiGraft can be easily prepared at the patient's bedside in 12 minutes.
- Ready to use right out of the box. Eliminates need for complex processing, temperature monitoring or storage (ActiGraft requires ambient temperature storage conditions).
Reduced Costs
- Because ActiGraft uses the patient’s own blood, we aren’t required to register as a tissue donor bank or go through the regulatory recording processes of skin substitutes. This reduces administration and documentation requirements.
- No capital equipment requirements.
- Reduced costs compared to other chronic wound treatments.
Increased Patient Safety and Comfort
- Autologous blood clot allows the body’s natural wound healing processes to operate.
- Fast healing with less wound interaction.
- Patients have reported improved quality of life.
ActiGraft can be used for a wide variety of hard-to-treat chronic wounds, including but not limited to:
- Diabetic/Neuropathic ulcers
- Pressure Ulcers/Injury
- Venous Stasis Ulcers
- Surgical Debridement wounds
- Traumatic wounds
- Skin Tears
Contraindications:
ActiGraft is contraindicated in patients with the following types of wounds:
- Wounds due to malignancy
- Wounds with active clinically diagnosed infection
- Radius of ActiGraft clot – 3cm (Diameter 6sq cm)
- Clot size: 28.3sq cm
- 20ml of blood required
- Storage conditions - Store in the original container at a room temperature of 5°C (41°F) – 30°C (86°F). Protect from freezing and avoid excessive heat.
Interested in Introducing ActiGraft
into your Practice?
ActiGraft® Virtual Training is a quick and easy program designed to fit your busy schedule. Begin treating patients immediately within your health care setting.
